News for 'drug money'

Say NO to drugs, it's not cool: PM Modi on Mann ki Baat

Say NO to drugs, it's not cool: PM Modi on Mann ki Baat

Rediff.com14 Dec 2014

Voicing concern over the "devastating" drug addiction menace, Prime Minister Narendra Modi on Sunday said society as well as the government will have to work together to fight this problem and that a helpline would be set up soon to assist those seeking solutions.

Cancer drug prices highest in US, treatment expensive in India

Cancer drug prices highest in US, treatment expensive in India

Rediff.com6 Jun 2016

The lowest drug prices were found in India and South Africa.

Aaditya Thackeray moves HC, seeks to be heard in Sushant death case PIL

Aaditya Thackeray moves HC, seeks to be heard in Sushant death case PIL

Rediff.com18 Oct 2023

Shiv Sena (UBT) MLA Aaditya Thackeray has moved the Bombay high court seeking to be heard before any order is passed in a public interest litigation demanding a CBI probe in connection with the deaths of actor Sushant Singh Rajput and his former manager Disha Salian.

12th pass cybercriminal, who made Rs 5cr a day, held in Mumbai

12th pass cybercriminal, who made Rs 5cr a day, held in Mumbai

Rediff.com3 May 2023

Mastermind Shrinivas Rao Dadi, 49, who has sound technical knowledge despite limited education, was taken into custody by a team of Bangur Nagar police station from a plush hotel in Hyderabad, the official said.

NDA more eager to cap drug prices than UPA

NDA more eager to cap drug prices than UPA

Rediff.com14 Jan 2016

The impact from NELM on the Indian pharmaceutical sector is estimated to be around Rs 6,000 crore.

Ranbaxy's malaria drug awaits international nod

Ranbaxy's malaria drug awaits international nod

Rediff.com14 Nov 2011

Health experts attribute this to the absence of international approval for the drug. About 90 per cent of malaria infections are reported from sub-Saharan Africa.

Ministries clash over cap on foreign stakes in drug firms

Ministries clash over cap on foreign stakes in drug firms

Rediff.com28 Nov 2013

The finance ministry is resisting pressure from other departments to cap foreign ownership of domestic drugmakers, fearing such a move would discourage potential investors, a senior ministry source said.

US regulator fast-tracks approval for Wockhardt drugs

US regulator fast-tracks approval for Wockhardt drugs

Rediff.com1 Sep 2014

These drugs will be entering in their global Phase -3 clinical trials early next year.

ED attaches Indian properties of Sri Lankan behind plot to kill Chandrika

ED attaches Indian properties of Sri Lankan behind plot to kill Chandrika

Rediff.com1 Sep 2022

The Enforcement Directorate on Thursday said it has attached Indian assets of a Sri Lankan man and his son as part of a drugs-linked money laundering investigation against them.

US launches biggest crackdown on designer drugs

US launches biggest crackdown on designer drugs

Rediff.com27 Jun 2013

The source of the synthetic drugs was Asia, especially India and China.

DGCA to make drug test a must for pilots, crew members

DGCA to make drug test a must for pilots, crew members

Rediff.com26 Aug 2021

The Directorate General of Civil Aviation (DGCA) has released a draft procedure that calls for testing pilots, other aviation personnel and crew members for psychoactive substances before they take to the skies. The Indian civil aviation regulator has sought comments from stakeholders over the next 30 days before issuing a regulation to this effect. Asking airlines and airports to do random checks on crew and air traffic controllers, DGCA proposed that violators be suspended for a minimum of three years or their licence be permanently cancelled as maximum punishment.

Dr Reddy's to launch Covid drugs remdesivir and favipiravir in August

Dr Reddy's to launch Covid drugs remdesivir and favipiravir in August

Rediff.com30 Jul 2020

Apart from favipiravir and remdesivir, its key Covid-19 products, DRL has already launched nutraceutical products and hand sanitisers during the pandemic.

Natco medicine gets 'Orphan Drug' status

Natco medicine gets 'Orphan Drug' status

Rediff.com29 Mar 2011

Natco Pharma's anti-cancer drug, NRC-AN-019, has received 'Orphan Drug' designation from the US Food and Drug Administration (USFDA) for three indications - glioma (brain tumour), pancreatic cancer and chronic myelogenous leukemia.

'Most countries won't forgive deaths of children'

'Most countries won't forgive deaths of children'

Rediff.com22 Nov 2022

'The deaths of the children in the Gambia would batter India's reputation as the developing world's pharmacy.'

USFDA pulls up Sun Pharma for lapses in Halol plant

USFDA pulls up Sun Pharma for lapses in Halol plant

Rediff.com14 Jan 2023

The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant. In a warning letter, the US Food and Drug Administration (USFDA) pointed out various lapses at the Halol plant which produces finished pharmaceutical products. "This warning letter summarises significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals... Because your methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to CGMP, your drug products are adulterated," the USFDA stated.

AFI chief warns athletes not to take banned drugs by taking advantage of COVID-19 pandemic

AFI chief warns athletes not to take banned drugs by taking advantage of COVID-19 pandemic

Rediff.com31 Oct 2020

AFI President Adille Sumariwalla raised the possibility of more athletes outside the national camp taking to banned drugs and laid a lot of blame on the district and state level coaches.

509 essential drugs to be costlier

509 essential drugs to be costlier

Rediff.com8 Apr 2015

The government regulates prices of all other medicines.

Ranbaxy to launch more drugs in US

Ranbaxy to launch more drugs in US

Rediff.com13 Jun 2013

Drug major Ranbaxy Laboratories on Thursday said it plans to launch more generic products in the US market with possible marketing exclusivity, while keeping options open for overseas acquisitions to grow its business in various global markets.

New rules for Indian generic drug makers

New rules for Indian generic drug makers

Rediff.com29 Oct 2012

Regulator says fee would enable it to quicken approval process.

Ranbaxy discontinues arthritis drug

Ranbaxy discontinues arthritis drug

Rediff.com12 Apr 2005

Ranbaxy Laboratories Ltd on Tuesday said it has decided to discontinue all its 'Valdecoxib' formulations with immediate effect from Indian markets.

1 in 7 Indian drugs revealed as substandard

1 in 7 Indian drugs revealed as substandard

Rediff.com16 Feb 2016

More lucrative routinely prescribed drugs are at higher risk of failing quality standards

Anti-cancer drugs to be cheaper soon

Anti-cancer drugs to be cheaper soon

Rediff.com18 Jun 2013

The drug pricing regulator on Tuesday said it will fix the ceiling prices of over 300 medicines by the end of this month, a move that will come as a major relief to patients.

Surge in cases of fake drugs

Surge in cases of fake drugs

Rediff.com11 Feb 2013

Of the 137,000 drug government tested 345 turned out to be fake.

Government notifies new drug pricing policy

Government notifies new drug pricing policy

Rediff.com13 Dec 2012

It will bring 348 essential drugs under price control.

The former drug addict who turns trash into livelihood

The former drug addict who turns trash into livelihood

Rediff.com8 Aug 2017

After spending 16 years on the streets as a crack cocaine addict, Fabiana da Silva has not only kicked her addiction and found a way to make a living, she has also earned a degree!

Govt cuts prices of 10 drugs, brings 8 more under control

Govt cuts prices of 10 drugs, brings 8 more under control

Rediff.com16 Sep 2016

With these 18 drugs, the government now has brought in 467 medicines under the price control.

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Rediff.com14 Mar 2023

In contrast with their strong performance in 2020 and 2021, pharmaceutical and healthcare funds experienced a decline in 2022, with returns plummeting by an average 9.8 per cent. This trend has continued in the current year, with year-to-date return remaining in the negative (-4.9 per cent). In the past three months, pharma funds have been hit hard, experiencing a 7.9 per cent decline.

Drugs ban: Partial relief for Wockhardt, Glaxo & Griffon

Drugs ban: Partial relief for Wockhardt, Glaxo & Griffon

Rediff.com18 Mar 2016

The Delhi High Court on Friday stayed the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.

Govt to review suspension of 3 drugs

Govt to review suspension of 3 drugs

Rediff.com10 Jul 2013

Besides opposing the suspension of three medicines, the sector has also questioned the process adopted by the government.

Drug firms on outsourcing high

Drug firms on outsourcing high

Rediff.com7 Jun 2010

An increase in the number of outsourcing deals between domestic drug companies and pharmaceutical multinationals has triggered huge capacity expansion programmes in the drug manufacturing sector.

Why cold wave across US is good news for Indian drug cos

Why cold wave across US is good news for Indian drug cos

Rediff.com12 Mar 2019

Companies such as Cadila Healthcare, Lupin, and Natco, which sell generic versions of flu medication in the US market, are likely to benefit.

Three controversial drugs may be banned

Three controversial drugs may be banned

Rediff.com25 Nov 2010

The Central Drugs Standard Control Organisation (CDSCO), the apex drug regulator, may soon ban the production and sale of three medicines in the country. The drugs - cisapride, phenylpropanolamine (PPA) and human placenta extracts - have been controversial medicines for their alleged adverse reactions for several years now.

Wait for cheaper drugs might get longer

Wait for cheaper drugs might get longer

Rediff.com3 Mar 2016

Lobby group tells USTR it has got assurance from India on compulsory licensing.

Domestic pharma market grew by 6.8% in 2023

Domestic pharma market grew by 6.8% in 2023

Rediff.com22 Jan 2024

The Indian pharmaceutical market (IPM) grew 6.8 per cent to touch a turnover of ~1.93 trillion in calendar year 2023, despite volumes going down marginally by 0.9 per cent. This indicates the price increase has been the major growth driver. Growth in the moving annual turnover (the previous 12 months' turnover) in December was 5.1 per cent and that in new product introduction 2.6 per cent, while volumes dipped 0.9 per cent, leading to an overall growth rate of 6.8 per cent, according to the data from market research firm Pharmatrac.

India partly revokes Roche cancer drug patent

India partly revokes Roche cancer drug patent

Rediff.com5 Aug 2013

Roche has already adapted its business model in India to increase affordable access to drugs and try to stave off trouble from India's patent authorities.

The political roots of black money

The political roots of black money

Rediff.com14 Jan 2015

An enormous amount of black money flows in and out of the banking system and still remains black.

Glenmark gets USFDA nod for drug

Glenmark gets USFDA nod for drug

Rediff.com19 Jun 2013

Riluzole is indicated for the treatment of amyotrophic lateral sclerosis.

'What Bigger Award One Can Hope For?'

'What Bigger Award One Can Hope For?'

Rediff.com4 Jul 2024

I did not take up research for any award.' 'What is more important is the medicine that I have developed.' 'This helps the patient recover and the family is happy that their relative has survived and they go back to their lives.

New device can sniff out smuggled money

New device can sniff out smuggled money

Rediff.com18 Aug 2014

riminals smuggle an estimated $30 billion in US currency into Mexico each year from the US, researchers said.

Are Ranbaxy drugs available in India safe?

Are Ranbaxy drugs available in India safe?

Rediff.com30 Jan 2014

If I follow US standards, I will have to shut almost all drug facilities: G N Singh